R. Wurtz et S. Ceaser, Adipose redistribution in human immunodeficiency virus-seropositive patients: Association with CD4 response, CLIN INF D, 31(6), 2000, pp. 1497-1498
We have noted that human immunodeficiency virus (HIV)-seropositive patients
who develop adipose redistribution (AR) while receiving combination antire
troviral therapy (ART) also tend to have a better response to ART, as indic
ated by the relative change in CD4 percent compared to those who don't deve
lop AR on therapy. Whether the possible benefits of the improved CD4 respon
se outweigh the metabolic and cosmetic problems associated with lipodystrop
hy is not known.